Skip to main content

Table 1 Clinicopathologic characteristics of patients with SMLC

From: Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort

Case Sex Age Tumor Site Size (cm) LM Type Subtype(%) Histologic type
L A P M S
1 F 62 01 LUL 2.5 N AP 0 100 0 0 0  
02 RUL 3.5   ASC N/A N/A N/A N/A N/A  
2 F 51 01 RLL 0.6 N AIS 100 0 0 0 0  
02 RLL 0.4   AIS 100 0 0 0 0  
3 F 55 01 RUL 0.4 N AIS 100 0 0 0 0  
02 RML 0.8   LP 80 20 0 0 0  
4 F 43 01 RLL 0.3 N AIS 100 0 0 0 0  
02 RML 0.7   LP 60 40 0 0 0  
03 LUL 0.5   AIS 100 0 0 0 0  
04 LLL 0.4   AIS 100 0 0 0 0  
5 F 51 01 RML 0.6 N AIS 100 0 0 0 0  
02 RLL 0.5   LP 70 30 0 0 0  
03 RLL 0.4   AIS 100 0 0 0 0  
6 F 75 01 RLL 1.5 N AP 20 80 0 0 0  
02 RUL 1.7   AP 0 70 20 10 0  
7 F 47 01 RLL 1.3 N AP 0 100 0 0 0  
02 RUL 0.5   AIS 100 0 0 0 0  
8 M 74 01 RUL 4 N AP 0 50 0 0 50  
02 RLL 0.7   MA N/A N/A N/A N/A N/A  
9 F 32 01 RLL 0.8 N AP 0 100 0 0 0  
02 RLL 0.5   AIS 100 0 0 0 0  
10 M 78 01 RUL 2.0 N SP 0 0 0 0 100  
02 RUL 1.4   AIS 100 0 0 0 0  
11 M 67 01 RLL 0.9 N AIS 100 0 0 0 0  
02 RLL 0.8   LP 60 20 20 0 0  
12 F 61 01 RUL 1.2 N AP 40 60 0 0 0  
02 RUL 0.9   LP 80 20 0 0 0  
03 RUL 0.9   AIS 100 0 0 0 0  
13 M 65 01 LUL 1.2 N LP 40 40 10 10 0  
02 LUL 1.1   LP 80 15 5 0 0  
03 RUL 0.5   AIS 100 0 0 0 0  
04 RLL 2.0   PP 20 30 40 10 0  
14 M 87 01 LLL 1 N AP 20 50 0 0 30  
02 LLL 1.3   AP 0 90 0 0 10  
15 M 50 01 LUL 0.5 N AP 0 100 0 0 0  
02 LUL 2.0   LP 55 45 0 0 0  
16 M 71 01 RUL 2 N AP 0 60 20 0 20  
02 RUL 0.8   AIS 100 0 0 0 0  
03 RUL 0.5   AIS 100 0 0 0 0  
04 RUL 0.8   AP 0 100 0 0 0  
17 M 63 01 RML 1.2 N LP 70 30 0 0 0  
02 RML 1   SP 0 20 0 0 80  
18 M 54 01 RML 1 Y SP 0 30 30 0 40  
02 RLL 0.4   LP 90 10 0 0 0  
19 F 65 01 RUL 1.2 Y AP 0 60 40 0 0  
02 RLL 1.1   AIS 100 0 0 0 0  
20 F 60 01 RLL 2.5 Y AP 30 70 0 0 0  
02 RUL 4   SP 0 40 0 0 60  
21 M 63 01 RLL 1.0 Y SP 0 10 10 0 80  
02 RML 0.5   AP 20 80 0 0 0  
  1. Abbreviations: A acinar, AIS adenocarcinoma in situ, AP acinar predominant, ASC adenosquamous carcinoma, F female, L lepidic, LLL left lower lobe, LM Lymph node metastasis, LP lepidic predominant, LUL left upper lobe, M male, M micropapillary, MA mucinous adenocarcinoma, N none, P papillary, PP papillary predominant, RLL right lower lobe, RML right middle lobe, RUL right upper lobe, S solid, SP solid predominant, Y yes